Literature DB >> 7618624

Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease.

G T Karatasakis1, A C Gotsis, D V Cokkinos.   

Abstract

The aim of this study was to investigate the influence of mitral regurgitation (MR) on left atrial (LA) thrombus formation and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease. LA thrombus and spontaneous contrast are considered risk factors for embolic complications. The presence of MR has been related to a low incidence of embolization; however, its effect on thrombus formation and spontaneous contrast has not been clarified. We studied by transesophageal echocardiography 55 patients with rheumatic mitral valve disease, who were receiving anticoagulant treatment. Atrial thrombus was detected in 13 patients who had a lower incidence of significant MR (p < 0.03), a smaller regurgitant jet (p < 0.02), and a higher incidence of atrial fibrillation (p < 0.05) than the rest of the group. Spontaneous contrast was detected in 34 patients with larger atria (p < 0.006), smaller regurgitant jets (p < 0.05), a smaller mitral valve area (p < 0.008), and a higher incidence of atrial fibrillation (p < 0.002) than the rest of the group. Patients without significant MR are at high risk for LA thrombus formation and subsequent embolization and represent a subgroup in whom careful anticoagulation is needed. Conversely, the presence of significant MR correlates with a lower incidence of spontaneous contrast, thrombi, and embolization.

Entities:  

Mesh:

Year:  1995        PMID: 7618624     DOI: 10.1016/s0002-9149(99)80081-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Bilateral atrial appendage thrombus formation in a patient with atrial fibrillation.

Authors:  Ayano Enzan; Koichiro Imai; Teruyoshi Kume; Tomoko Tamada; Kikuko Obase; Ryotaro Yamada; Yoji Neishi; Shiro Uemura
Journal:  J Echocardiogr       Date:  2015-07-24

Review 2.  Current Perspectives: Rheumatic Atrial Fibrillation.

Authors:  Bhima Shankar P R; Hygriv Roa B; S Jaishankar; M Narasimhan
Journal:  J Atr Fibrillation       Date:  2010-03-01

3.  The effect of transient balloon occlusion of the mitral valve on left atrial appendage blood flow velocity and spontaneous echo contrast.

Authors:  J Wang; D Chung Ann Choo; X Zhang; Q Yang; T Xian; D Lu; S Jiang
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

4.  Left atrial appendage functions in patients with severe rheumatic mitral regurgitation.

Authors:  Atila Bitigen; Mustafa Bulut; Ali C Tanalp; Cevat Kirma; Irfan Barutçu; Selcuk Pala; Ayhan Erkol; Bilal Boztosun
Journal:  Int J Cardiovasc Imaging       Date:  2007-02-13       Impact factor: 2.357

5.  External validation and comparison of CHA2DS2-VASc-RAF and CHA2DS2-VASc-LAF scores for predicting left atrial thrombus and spontaneous echo contrast in patients with non-valvular atrial fibrillation.

Authors:  Nan Zheng; Jun Zhang
Journal:  J Interv Card Electrophysiol       Date:  2022-07-13       Impact factor: 1.759

6.  Formation of a left atrial thrombus during percutaneous mitral valve edge-to-edge repair induced by acute reduction of mitral regurgitation.

Authors:  Andreas Glatthaar; Peter Seizer; Johannes Patzelt; Harald Langer; Jürgen Schreieck; Meinrad Gawaz
Journal:  J Cardiol Cases       Date:  2017-09-22

7.  Analysis of a coupled fluid-structure interaction model of the left atrium and mitral valve.

Authors:  Liuyang Feng; Hao Gao; Boyce Griffith; Steven Niederer; Xiaoyu Luo
Journal:  Int J Numer Method Biomed Eng       Date:  2019-11       Impact factor: 2.747

8.  Prognostic significance of spontaneous echocardiographic contrast detected by transthoracic and transesophageal echocardiography in the era of harmonic imaging.

Authors:  Karolina Kupczyńska; Jarosław D Kasprzak; Błażej Michalski; Piotr Lipiec
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

9.  Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.

Authors:  Günter Breithardt; Helmut Baumgartner; Scott D Berkowitz; Anne S Hellkamp; Jonathan P Piccini; Yuliya Lokhnygina; Jonathan L Halperin; Daniel E Singer; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Kenneth W Mahaffey; Robert M Califf; Keith A A Fox; Manesh R Patel
Journal:  Heart       Date:  2016-02-17       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.